VEGFR1 Antibodies

Santa Cruz Biotechnology delivers a wide array of VEGFR1 monoclonal antibodies for research in vascular biology and angiogenesis. VEGFR1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) plays a critical role in the regulation of angiogenesis and the maintenance of vascular homeostasis. VEGFR1 is involved in the signaling pathways that control endothelial cell proliferation, migration, and survival, making it a key player in both normal physiological processes and pathological conditions such as cancer and ischemia. Understanding VEGFR1 function is essential for developing targeted therapies in diseases characterized by abnormal blood vessel formation. VEGFR1 monoclonal antibodies can be conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) to enhance detection capabilities. Researchers worldwide rely on VEGFR1 monoclonal antibodies to advance vascular biology research and contribute to therapeutic developments. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by enabling researchers to uncover new insights in vascular biology and potential therapeutic targets.